Clinical Trial Update: A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study of LY3549492 in adults with obesity or overweight with type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• LY3549492 (LY3549492)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 2 | Status: TERMINATED